NCT07284758Phase 2Recruiting

A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma

Study sponsor: C4 Therapeutics, Inc. · CCCC

Primary completion is the date data collection ends for the main study measures, not when results are published.

Primary completion2030-03Estimated
Enrollment · participants100Estimated
Source updated2026-10-30Last update listed in the registry record

Changes to this trial

Last 12 months
Filters
Clear filters

· 1 field changed

Recruitment status changed

Before: Not yet recruiting. After: Recruiting.

Check registry source